Menkes Syndrome: Comparison
Please note this is a comparison between Version 1 by Rita Xu and Version 2 by Rita Xu.

Menkes syndrome is a disorder that affects copper levels in the body.

  • genetic conditions

1. Introduction

It is characterized by sparse, kinky hair; failure to gain weight and grow at the expected rate (failure to thrive); and deterioration of the nervous system. Additional signs and symptoms include weak muscle tone (hypotonia), sagging facial features, seizures, developmental delay, and intellectual disability. Children with Menkes syndrome typically begin to develop symptoms during infancy and often do not live past age 3. Early treatment with copper may improve the prognosis in some affected individuals. In rare cases, symptoms begin later in childhood.

Occipital horn syndrome (sometimes called X-linked cutis laxa) is a less severe form of Menkes syndrome that begins in early to middle childhood. It is characterized by wedge-shaped calcium deposits in a bone at the base of the skull (the occipital bone), coarse hair, and loose skin and joints.

2. Frequency

The incidence of Menkes syndrome and occipital horn syndrome is estimated to be 1 in 100,000 newborns.

3. Causes

Mutations in the ATP7A gene cause Menkes syndrome. The ATP7A gene provides instructions for making a protein that is important for regulating copper levels in the body. Copper is necessary for many cellular functions, but it is toxic when present in excessive amounts. Mutations in the ATP7A gene result in poor distribution of copper to the body's cells. Copper accumulates in some tissues, such as the small intestine and kidneys, while the brain and other tissues have unusually low levels of copper. The decreased supply of copper can reduce the activity of numerous copper-containing enzymes that are necessary for the structure and function of bone, skin, hair, blood vessels, and the nervous system. The signs and symptoms of Menkes syndrome and occipital horn syndrome are caused by the reduced activity of these copper-containing enzymes.

45. Inheritance

Menkes syndrome is inherited in an X-linked recessive pattern. The gene associated with this condition is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

In about one-third of cases, Menkes syndrome is caused by new mutations in the ATP7A gene. People with a new mutation do not have a history of the disorder in their family.

56. Other Names for This Condition

  • copper transport disease
  • hypocupremia, congenital
  • kinky hair syndrome
  • Menkea syndrome
  • Menkes Disease
  • MK
  • MNK
  • Steely Hair Syndrome
  • X-linked copper deficiency


  1. Barnes N, Tsivkovskii R, Tsivkovskaia N, Lutsenko S. The copper-transportingATPases, menkes and wilson disease proteins, have distinct roles in adult anddeveloping cerebellum. J Biol Chem. 2005 Mar 11;280(10):9640-5.
  2. Bertini I, Rosato A. Menkes disease. Cell Mol Life Sci. 2008 Jan;65(1):89-91. Review.
  3. de Bie P, Muller P, Wijmenga C, Klomp LW. Molecular pathogenesis of Wilson andMenkes disease: correlation of mutations with molecular defects and diseasephenotypes. J Med Genet. 2007 Nov;44(11):673-88.
  4. Donsante A, Tang J, Godwin SC, Holmes CS, Goldstein DS, Bassuk A, Kaler SG.Differences in ATP7A gene expression underlie intrafamilial variability in Menkesdisease/occipital horn syndrome. J Med Genet. 2007 Aug;44(8):492-7.
  5. Harris ED. Basic and clinical aspects of copper. Crit Rev Clin Lab Sci. 2003Oct;40(5):547-86. Review.
  6. Kaler SG, Holmes CS, Goldstein DS, Tang J, Godwin SC, Donsante A, Liew CJ,Sato S, Patronas N. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med. 2008 Feb 7;358(6):605-14. doi: 10.1056/NEJMoa070613.
  7. Kaler SG. ATP7A-Related Copper Transport Disorders. 2003 May 9 [updated 2016Aug 18]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K,Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University ofWashington, Seattle; 1993-2020. Available from
  8. Lutsenko S, Washington-Hughes C, Ralle M, Schmidt K. Copper and the brainnoradrenergic system. J Biol Inorg Chem. 2019 Dec;24(8):1179-1188. doi:10.1007/s00775-019-01737-3.
  9. Madsen E, Gitlin JD. Copper deficiency. Curr Opin Gastroenterol. 2007Mar;23(2):187-92. Review.
  10. Menkes JH. Menkes disease and Wilson disease: two sides of the same coppercoin. Part I: Menkes disease. Eur J Paediatr Neurol. 1999;3(4):147-58. Review.
  11. National Institute of Neurological Disorders and Stroke
  12. Prohaska JR. Role of copper transporters in copper homeostasis. Am J ClinNutr. 2008 Sep;88(3):826S-9S.
  13. Tang J, Robertson S, Lem KE, Godwin SC, Kaler SG. Functional copper transport explains neurologic sparing in occipital horn syndrome. Genet Med. 2006Nov;8(11):711-8.
  14. Voskoboinik I, Camakaris J. Menkes copper-translocating P-type ATPase (ATP7A):biochemical and cell biology properties, and role in Menkes disease. J BioenergBiomembr. 2002 Oct;34(5):363-71. Review.
Video Production Service